Noticias Viridian Therapeutics Inc - VRDN | Acciones NASDAQ | ADVFN

US Dollar vs MXN

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Viridian Therapeutics Inc (VRDN)
Viridian Therapeutics Inc (VRDN) Noticias

Viridian Therapeutics Inc (VRDN)

15.92

0.11

(0.70%)

Cerrado 14 Marzo 2:00PM

Delayed by 15 minutes

15.92

0.01

(0.06%)

Fuera de horario: 3:30PM

Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2024 Financial Results

- Reported positive topline phase 3 data for veligrotug from both THRIVE and THRIVE-2 in patients with active and chronic thyroid eye disease...

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines...

Monksdream

Monksdream 6 meses hace

VRDN more upside possible

it_happens

it_happens 6 meses hace

Touched 20s today. Maybe it will stay above 20 tomorrow

power11

power11 6 meses hace

LOW 20'S BY WEEKEND IMO !!!
GOOD LUCK

it_happens

it_happens 6 meses hace

Good news. I don't think that this is merely a one-day runner.

power11

power11 6 meses hace

BTIG RESEARCH ADJUST PRICE TARGET TO 56 FROM 46; STRONG BUY !!

it_happens

it_happens 6 meses hace

Over 15 and having a good day today

Monksdream

Monksdream 6 meses hace

Apprentice

Apprentice 3 años hace

I put into it a lot of $
423 shares!

Apprentice

Apprentice 3 años hace

It just doesn't want to move above $18
Yet, it's not diving much either.
What do you think at this point? Sell temporarily and by later low?
My average is too high @17.76 !

crudeoil24

crudeoil24 3 años hace

Viridian Therapeutics, Inc., formerly Miragen Therapeutics, Inc., is a biotechnology company. The Company is engaged in developing multiple product candidates to treat patients who suffer from thyroid eye disease (TED), a debilitating orphan disease, and has early-stage programs focused on other targets and indications. Its lead candidate, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody (mAb) that is under development for thyroid eye disease (TED). The Company's TED pipeline also includes VRDN-002 and VRDN-003. Its other programs include VRDN-004, which is under development for undisclosed rare orphan disease, and VRDN-005, which is under development for tick-borne disease (TBD). The Company also out licenses its programs.

Viridian Therapeutics

Exchange Trading Funds

SilverSun Technologies

Ossiam Lux (CE)

Inv Eu 600 Bank

Yutex Holding Ad

Vontobel Financial Produ...

Vontobel Financial Produ...

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones